GEMER SITA (Sitagliptin (50mg) + Glimepiride (2mg) + Metformin (500mg))

Gemer Sita IR 50/500/2 Tablet is a formulation that combines three different medications aimed at managing elevated blood glucose levels in individuals diagnosed with type 2 diabetes mellitus. This treatment option is typically recommended for patients who have not achieved sufficient glucose control through lifestyle changes, including diet and exercise, or other therapeutic measures. It is advisable to take the tablet alongside food to enhance absorption and minimize gastrointestinal discomfort. To achieve optimal results, it is essential to maintain a consistent daily schedule for taking the medication. The healthcare provider will determine the appropriate dosage and treatment duration based on the patient’s specific medical condition and response to the medication. Regular monitoring of blood sugar levels is often conducted to ensure effective management of diabetes while on this combination therapy. Patients are encouraged to continue taking the medication even if they feel stable or their blood sugar appears controlled, as discontinuation can lead to increased glucose levels and potential health complications. This medication is an integral part of a broader diabetes management plan that also emphasizes a balanced diet, physical activity, and weight management, all of which are crucial in maintaining optimal blood sugar levels. Use this medicine only under medical supervision. Follow the dose and schedule exactly as advised. Do not stop abruptly without guidance. Keep a record of any unusual symptoms and share them with your clinician. Combine therapy with appropriate lifestyle measures and routine monitoring as recommended.